StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by 2021Gambleon Nov 23, 2021 10:29am

145 Views

Post# 34156827

TSX net house szls.wt warrants

Broker   Broker Name   Buy Average   Buy Volume   Sell Average   Sell Volume   Net Volume
009   BMO Nesbitt Burns Inc.   0.030   50000   0.000   0   50000
033   Canaccord Genuity Corp.   0.035   1000   0.000   0   1000
088   Credential Securities Inc.   0.035   28000   0.000   0   28000
007   TD Securities Inc.   0.033   118000   0.035   10000   108000
001   Anonymous   0.035   52000   0.035   32000   20000
079   CIBC World Markets Inc.   0.000   0   0.030   50000   -50000
124   Questrade Inc.   0.035   2000   0.030   57000   -55000
002   RBC Capital Markets   0.000   0   0.035   102000   -102000

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports